Showing results (51-60 of 84) with videos related to
Sort By:
Pageof 9
Cancer Research|February 14, 2023
Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial TherapyAndrew O Yam, Jacqueline Bailey, Francis Lin, et al.Nature Communications|September 12, 2025
Matrix directs trophoblast differentiation in a bioprinted organoid model of early placental developmentClaire Richards, Hao Chen, Matthew O'Rourke, et al.Cancer Research|February 5, 2013
Involvement of Lyn and the atypical kinase SgK269/PEAK1 in a basal breast cancer signaling pathwayDavid R Croucher, Falko Hochgräfe, Luxi Zhang, et al.Iscience|June 15, 2026
Stromal peroxidasin drives early tumor growth in breast cancerKaitlin Wyllie, Ellie T Y Mok, Que Emmi Tran, et al.Scientific Reports|November 18, 2017
Andy's Algorithms: new automated digital image analysis pipelines for FIJIAndrew M K Law, Julia X M Yin, Lesley Castillo, et al.The Journal of Experimental Medicine|February 24, 2023
Pleiotrophin drives a prometastatic immune niche in breast cancerDebolina Ganguly, Marcel O Schmidt, Morgan Coleman, et al.Journal of Experimental & Clinical Cancer Research : CR|February 12, 2025
A combination of PD-1 and TIGIT immune checkpoint inhibitors elicits a strong anti-tumour response in mesotheliomaHuaikai Shi, Ta-Kun Yu, Ben Johnson, et al.Annals of Surgical Oncology|November 13, 2008
TWIST1 overexpression is associated with nodal invasion and male sex in primary colorectal cancerFátima Valdés-Mora, Teresa Gómez del Pulgar, Eva Bandrés, et al.Plos Genetics|January 3, 2020
ELF5 modulates the estrogen receptor cistrome in breast cancerCatherine L Piggin, Daniel L Roden, Andrew M K Law, et al.Molecular Cancer Therapeutics|July 18, 2013
BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancerAndrew Stone, Mark J Cowley, Fatima Valdes-Mora, et al.Pageof 9